Griffin, J.; Wu, Y.; Mu, Q.; Li, X.; Ho, R.J.Y.
Design and Characterization of a Novel Venetoclax-Zanubrutinib Nano-Combination for Enhancing Leukemic Cell Uptake and Long-Acting Plasma Exposure. Pharmaceutics 2023, 15, 1016.
https://doi.org/10.3390/pharmaceutics15031016
AMA Style
Griffin J, Wu Y, Mu Q, Li X, Ho RJY.
Design and Characterization of a Novel Venetoclax-Zanubrutinib Nano-Combination for Enhancing Leukemic Cell Uptake and Long-Acting Plasma Exposure. Pharmaceutics. 2023; 15(3):1016.
https://doi.org/10.3390/pharmaceutics15031016
Chicago/Turabian Style
Griffin, James, Yan Wu, Qingxin Mu, Xinyan Li, and Rodney J. Y. Ho.
2023. "Design and Characterization of a Novel Venetoclax-Zanubrutinib Nano-Combination for Enhancing Leukemic Cell Uptake and Long-Acting Plasma Exposure" Pharmaceutics 15, no. 3: 1016.
https://doi.org/10.3390/pharmaceutics15031016
APA Style
Griffin, J., Wu, Y., Mu, Q., Li, X., & Ho, R. J. Y.
(2023). Design and Characterization of a Novel Venetoclax-Zanubrutinib Nano-Combination for Enhancing Leukemic Cell Uptake and Long-Acting Plasma Exposure. Pharmaceutics, 15(3), 1016.
https://doi.org/10.3390/pharmaceutics15031016